Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Harald Paganetti. (2017) Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in α/β. Acta Oncologica 56:11, pages 1379-1386.
Read now
Read now
Wolfgang A. Tomé, John D. Fenwick & Søren M. Bentzen. (2006) Does a local bystander effect necessitate a revision of TCP models that are based on observed clinical data?. Acta Oncologica 45:4, pages 406-411.
Read now
Read now
Jochen Willner. (1999) Tumor Volume and Local Control in Primary Radiotherapy of Nasopharyngeal Carcinoma. Acta Oncologica 38:8, pages 1025-1030.
Read now
Read now
J. H. HENDRY and C. M. L. WEST. (1997) Apoptosis and mitotic cell death: their relative contributions to normal-tissue and tumour radiation response. International Journal of Radiation Biology 71:6, pages 709-719.
Read now
Read now
S. L. TUCKER and J. M. G. TAYLOR. (1996) Improved models of tumour cure. International Journal of Radiation Biology 70:5, pages 539-553.
Read now
Read now
SØRen M. Bentzen. (1993) Quantitative Clinical Radiobiology. Acta Oncologica 32:3, pages 259-275.
Read now
Read now
Articles from other publishers (46)
Clemens Grassberger, David McClatchyIIIIII, Changran Geng, Sophia C. Kamran, Florian Fintelmann, Yosef E. Maruvka, Zofia Piotrowska, Henning Willers, Lecia V. Sequist, Aaron N. Hata & Harald Paganetti. (2019) Patient-Specific Tumor Growth Trajectories Determine Persistent and Resistant Cancer Cell Populations during Treatment with Targeted Therapies. Cancer Research 79:14, pages 3776-3788.
Crossref
Crossref
Zhaodong Fei, Chuanben Chen, Yingying Huang, Xiufang Qiu, Yi Li, Li Li & Taojun Chen. (2019) Metabolic tumor volume and conformal radiotherapy based on prognostic PET/CT for treatment of nasopharyngeal carcinoma. Medicine 98:28, pages e16327.
Crossref
Crossref
Angus G. Dalgleish & Peter L. Stern. (2018) The failure of radical treatments to cure cancer: can less deliver more?. Therapeutic Advances in Vaccines and Immunotherapy 6:5-6, pages 69-76.
Crossref
Crossref
Søren M. Bentzen. 2018. Basic Clinical Radiobiology. Basic Clinical Radiobiology
44
53
.
J. Donald Chapman & Alan E. Nahum. 2016. Radiotherapy Treatment Planning. Radiotherapy Treatment Planning
103
112
.
Carsten Brink, Uffe Bernchou, Anders Bertelsen, Olfred Hansen, Tine Schytte & Soren M. Bentzen. (2014) Locoregional Control of Non-Small Cell Lung Cancer in Relation to Automated Early Assessment of Tumor Regression on Cone Beam Computed Tomography. International Journal of Radiation Oncology*Biology*Physics 89:4, pages 916-923.
Crossref
Crossref
N. Patrik Brodin, Maja V. Maraldo, Marianne C. Aznar, Ivan R. Vogelius, Peter M. Petersen, Søren M. Bentzen & Lena Specht. (2014) Interactive Decision-Support Tool for Risk-Based Radiation Therapy Plan Comparison for Hodgkin Lymphoma. International Journal of Radiation Oncology*Biology*Physics 88:2, pages 433-445.
Crossref
Crossref
Brian A. Hrycushko, Shihong Li, Beth Goins, Randal A. Otto & Ande Bao. (2011) Direct intratumoral infusion of liposome encapsulated rhenium radionuclides for cancer therapy: Effects of nonuniform intratumoral dose distribution. Medical Physics 38:3, pages 1339-1347.
Crossref
Crossref
Francesca M. Buffa. 2009. Radiotherapy and Brachytherapy. Radiotherapy and Brachytherapy
3
9
.
C. P. South, M. Partridge & P. M. Evans. (2008) A theoretical framework for prescribing radiotherapy dose distributions using patient-specific biological information. Medical Physics 35:10, pages 4599-4611.
Crossref
Crossref
Colleen Schinkel, Marco Carlone, Brad Warkentin & B. Gino Fallone. (2007) Analytic Investigation Into Effect of Population Heterogeneity on Parameter Ratio Estimates. International Journal of Radiation Oncology*Biology*Physics 69:4, pages 1323-1330.
Crossref
Crossref
Robert D. Stewart & X. Allen Li. (2007) BGRT: Biologically guided radiation therapy-The future is fast approaching!. Medical Physics 34:10, pages 3739-3751.
Crossref
Crossref
P J Keall & S Webb. (2007) Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution. Physics in Medicine and Biology 52:1, pages 291-302.
Crossref
Crossref
Stephen A Roberts & Jolyon H Hendry. 2007. Radiobiological Modelling in Radiation Oncology. Radiobiological Modelling in Radiation Oncology
169
195
.
M Zhang, V Moiseenko, M Liu & T Craig. (2006) Internal fiducial markers can assist dose escalation in treatment of prostate cancer: result of organ motion simulations. Physics in Medicine and Biology 51:2, pages 269-285.
Crossref
Crossref
B Warkentin, P Stavrev, N A Stavreva & B G Fallone. (2005) Limitations of a TCP model incorporating population heterogeneity. Physics in Medicine and Biology 50:15, pages 3571-3588.
Crossref
Crossref
V Moiseenko, M Mulligan & T Kron. (2004) RADIATION QUALITY OF A TOMOTHERAPY PHOTON FAN BEAM. Health Physics 87:2, pages 166-170.
Crossref
Crossref
David Murray, Razmik Mirzayans, April L. Scott & M. Joan Allalunis-Turner. (2003) Influence of Oxygen on the Radiosensitivity of Human Glioma Cell Lines. American Journal of Clinical Oncology 26:5, pages e169-e177.
Crossref
Crossref
Alan E Nahum, Benjamin Movsas, Eric M Horwitz, Corinne C Stobbe & J.Donald Chapman. (2003) Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the α/β ratio. International Journal of Radiation Oncology*Biology*Physics 57:2, pages 391-401.
Crossref
Crossref
Wolfgang A Tom & Jack F Fowler. (2003) On the inclusion of proliferation in tumour control probability calculations for inhomogeneously irradiated tumours. Physics in Medicine and Biology 48:18, pages N261-N268.
Crossref
Crossref
R M Wyatt, A H Beddoe & R G Dale. (2003) The effects of delays in radiotherapy treatment on tumour control. Physics in Medicine and Biology 48:2, pages 139-155.
Crossref
Crossref
N Stavreva, P Stavrev, B Warkentin & B G Fallone. (2002)
Derivation of the expressions for
50
and
D
50
for different individual TCP and NTCP models
. Physics in Medicine and Biology 47:20, pages 3591-3604.
Crossref
Crossref
Wolfgang A. Tomé & Jack F. Fowler. (2002) On cold spots in tumor subvolumes. Medical Physics 29:7, pages 1590-1598.
Crossref
Crossref
Søren M Bentzen, Michele I Saunders, Stanley Dische & Simon J Bond. (2001) Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiotherapy and Oncology 60:2, pages 123-135.
Crossref
Crossref
Francesca M. Buffa, John D. Fenwick & Alan E. Nahum. (2000) An analysis of the relationship between radiosensitivity and volume effects in tumor control probability modeling. Medical Physics 27:6, pages 1258-1265.
Crossref
Crossref
Gereon Kåver, Bengt K Lind, Johan Löf, Anders Liander & Anders Brahme. (1999) Stochastic optimization of intensity modulated radiotherapy to account for uncertainties in patient sensitivity. Physics in Medicine and Biology 44:12, pages 2955-2969.
Crossref
Crossref
Stephen A. Roberts & Jolyon H. Hendry D.Sc. (1999) Time factors in larynx tumor radiotherapy: lag times and intertumor heterogeneity in clinical datasets from four centers. International Journal of Radiation Oncology*Biology*Physics 45:5, pages 1247-1257.
Crossref
Crossref
R.I. Mackay & J.H. Hendry. (1999) The modelled benefits of individualizing radiotherapy patients’ dose using cellular radiosensitivity assays with inherent variability. Radiotherapy and Oncology 50:1, pages 67-75.
Crossref
Crossref
J D Fenwick. (1998) Predicting the radiation control probability of heterogeneous tumour ensembles: data analysis and parameter estimation using a closed-form expression. Physics in Medicine and Biology 43:8, pages 2159-2178.
Crossref
Crossref
Stephen A. Roberts & Jolyon H. Hendry. (1998) A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity. International Journal of Radiation Oncology*Biology*Physics 41:3, pages 689-699.
Crossref
Crossref
Steffen Appold, Michael Baumann, Cordula Petersen, Kirsten Horn & Frauke Eichhorn. (1998) Comparison of the Response of human FaDu squamous cell carcinoma in nude mice after hypofractionated-accelerated regimens and “curative” fractionation schedulesVergleich hypofraktioniert-akzelerierter mit „kurativen” Fraktionierungsschemata bei der Strahlentherapie humaner FaDu-Plattenepithelkarzinome in Nacktmäusen. Strahlentherapie und Onkologie 174:6, pages 315-319.
Crossref
Crossref
Hans-Hermann Dubben, Howard D Thames & Hans-Peter Beck-Bornholdt. (1998) Tumor volume: a basic and specific response predictor in radiotherapy. Radiotherapy and Oncology 47:2, pages 167-174.
Crossref
Crossref
V. A. Zinchenko. (1998) Radioresistance of tumor cells. Biopolymers and Cell 14:1, pages 12-18.
Crossref
Crossref
Stephen A. Roberts, Jolyon H. Hendry & Nicholas J. Slevin. (1997) Modelling the optimal radiotherapy regime for the control of T2 laryngeal carcinoma using parameters derived from several datasets. International Journal of Radiation Oncology*Biology*Physics 39:5, pages 1173-1182.
Crossref
Crossref
Søren M. Bentzen. (1997) Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. Radiotherapy and Oncology 43:2, pages 121-131.
Crossref
Crossref
Rainer K. Sachs, Wolfgang F. Heidenreich & David J. Brenner. (1996) Dose timing in tumor radiotherapy: Considerations of cell number stochasticity. Mathematical Biosciences 138:2, pages 131-146.
Crossref
Crossref
Søren M. Bentzen & Howard D. Thames. (1996) Tumor volume and local control probability: Clinical data and radiobiological interpretations. International Journal of Radiation Oncology*Biology*Physics 36:1, pages 247-251.
Crossref
Crossref
J.H. Hendry, S.M. Bentzen, R.G. Dale, J.F. Fowler, T.E. Wheldon, B. Jones, A.J. Munro, N.J. Slevin & A.G. Robertson. (1996) A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clinical Oncology 8:5, pages 297-307.
Crossref
Crossref
Christopher R. Johnson, Howard D. Thames, David T. Huang & Rupert K. Schmidt-Ullrich. (1995) The tumor voluem and clonogen number relationship: Tumor control predictions based upon tumor volume estimates derived from computed tomography. International Journal of Radiation Oncology*Biology*Physics 33:2, pages 281-287.
Crossref
Crossref
Søren M. Bentzen. (1995) Dose escalation, treatment protraction, and the steepness of the dose-response curve for squamous cell carcinoma of the head and neck. Radiotherapy and Oncology 34:1, pages 82-83.
Crossref
Crossref
Søren M. Bentzen. (1994) Radiobiological considerations in the design of clinical trials. Radiotherapy and Oncology 32:1, pages 1-11.
Crossref
Crossref
S.M. Bentzen. (1994) Prediction of radiotherapy response using SF2: Why it may work after all. Radiotherapy and Oncology 31:1, pages 85-86.
Crossref
Crossref
J.H. Hendry, C.M.L. West, J.V. Moore & C.S. Potten. (1994) Tumour stem cells: the relevance of predictive assays for tumour control after radiotherapy. Radiotherapy and Oncology 30:1, pages 11-16.
Crossref
Crossref
M. Baumann, A. Taghian & W. Budach. 1993. Current Topics in Clinical Radiobiology of Tumors. Current Topics in Clinical Radiobiology of Tumors
87
98
.
S. M. Bentze. 1993. Current Topics in Clinical Radiobiology of Tumors. Current Topics in Clinical Radiobiology of Tumors
11
26
.
Jolyon H. Hendry. (1992) Treatment acceleration in radiotherapy: the relative time factors and dose-response slopes for tumours and normal tissues. Radiotherapy and Oncology 25:4, pages 308-312.
Crossref
Crossref